Groups | Day after challenge | P value | |
---|---|---|---|
Day after the end of medication | Last day (before death) | ||
Untreated | – | 11,804,800 | P < 0.001 |
PYR | 1,870,800 | 916,000 | P < 0.001 |
P value | P < 0.009 | ||
Untreated | - | 11,804,800 | P < 0.001 |
FLU 20 mg + PYR | 1,746,000 | 1,052,000 | P < 0.001 |
P value | P < 0.009 | ||
Untreated | – | 11,804,800 | P < 0.001 |
FLU 40 mg + PYR | 1,592,400 | 1,556,000 | P < 0.001 |
P value | P < 0.009 | ||
Untreated | – | 11,804,800 | P < 0.001 |
FLU 80 mg + PYR | 2,466,000 | 2,004,400 | P < 0.001 |
P value | P < 0.009 |